Heart Failure Society of America to livestream late-breaking studies after meeting cancellation
The Heart Failure Society of America (HFSA) announced Thursday, Sept. 26, that it had to cancel its annual meeting, HFSA 2024, due to extreme weather associated with Hurricane Helene. The four-day event was originally scheduled to run Sept. 27-30 in Atlanta.
Just one day later, however, the group has some better news to share: HFSA 2024 will still live on through a series of livestreamed late-breaking clinical research sessions.
HFSA previously shared its full program of late-breaking studies, noting that some would take place on the meeting’s plenary session stage and others would be delivered via Rapid Fire sessions designed to be “fast-paced and brief.” Now, plans have been made to livestream those sessions Sept. 29 and 30 for anyone who had previously registered for the annual meeting. The recordings will then be available on demand on the meeting’s official website.
“The program committee received so much incredible and cutting-edge late breaking research this year, and we know that our registrants are eager to hear these trial results and research updates,” Mitchell Psotka, MD, PhD, chief of heart failure and transplant for the Inova Health System and program committee chair for HFSA 2024, said in a statement. “We want to bring you those results without further delay. We want to honor our commitment to the investigators and give them a platform through which they can share their research. This new format will present a different experience; but the most important thing is the science, and we’re excited to share that with you as scheduled.”
As this plan is still being finalized, HFSA has promised to keep providing updates through email and its social media channels as more information becomes available.
“We kindly ask for your patience as we navigate this unexpected situation,” HFSA President James C. Fang, MD, said in a previous statement.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.